QUSVM
Qiming U.S. Ventures Management Portfolio holdings
AUM
$23.6M
This Quarter Return
-34.18%
1 Year Return
-18.39%
3 Year Return
+715.34%
5 Year Return
–
10 Year Return
–
AUM
$72M
AUM Growth
+$72M
(-32%)
Cap. Flow
+$6.11M
Cap. Flow
% of AUM
8.48%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
HilleVax
HLVX
|
$6.11M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICVX
1
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $20.1M | 27.92% | 3,510,228 | – | – |
|
2
Tourmaline Bio
TRML
$601M
| $13.2M | 18.36% | 2,932,606 | – | – |
|
3
Jasper Therapeutics
JSPR
$45.5M
| $11.3M | 15.68% | 5,852,982 | – | – |
|
4
Ventyx Biosciences
VTYX
$171M
| $11.1M | 15.45% | 910,306 | – | – |
|
5
Kezar Life Sciences
KZR
$28.9M
| $6.85M | 9.51% | 828,711 | – | – |
|
|
6
HilleVax
HLVX
$105M
| $6.11M | 8.48% | +558,923 | New | +$6.11M |
|
|
ELEV
7
DELISTED
Elevation Oncology
ELEV
| $3.32M | 4.61% | 2,370,142 | – | – |
|